drugset / Trial / NCT07272330
A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This Phase I clinical trial will investigate the relative bioavailability between two formulations of HRS-1893 tablets and the influence of food on the drug's pharmacokinetics in healthy adult participants. The safety and tolerability of HRS-1893 will also be monitored.
Timeline
- Start
- 2025-12-11
- Primary completion
- 2026-03-21
- Completion
- 2026-03-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-1893 | Unknown | — | — |